Table 5 Pregnancy outcomes of 958 participants with follow-up data
|  | Live birth (N = 854) | Termination (N = 104) | Total (N = 958) |
|---|---|---|---|
Chromosomal aneuploidy | 4 (11.4%) | 31 (88.6%) | 35 (100.0%) |
 T21 | 1 (5.0%) | 19 (95.0%) | 20 (100.0%) |
 T18 | 0 (0.0%) | 4 (100.0%) | 4 (100.0%) |
 T13 | 0 (0.0%) | 2 (100.0%) | 2 (100.0%) |
 Sex chromosome abnormality | 3 (33.3%) | 6 (66.7%) | 9 (100.0%) |
P/LP CNVs | 21 (39.6%) | 32 (60.4%) | 53 (100.0%) |
 Microdeletion | 13 (34.2%) | 25 (65.8%) | 38 (100.0%) |
 microduplication | 8 (53.3%) | 7 (46.7%) | 15 (100.0%) |
VUS | 829 (95.3%) | 41 (4.7%) | 870 (100.0%) |